An mTOR inhibitor improved cognition and ameliorated AD pathology in a 5xTg AD model (32), highlighting the therapeutic potential of exploring the pathways involved in the bidirectional relationship between AD and seizures. Here, MTOR is linked to Alzheimer disease.